CAL02, which efficiently neutralizes pneumococcal toxins, proved to be safe and well tolerated; moreover, the CAL02 group displayed a clear trend to a faster resolution of the infection compared to placebo [ 24 ].
← all excerpts
Tailored liposomal nanotraps for the treatment of Streptococcal infections.
1
—
—